Enhances calcium absorption
Monitor calcium levels. Don't combine high-dose vitamin D with high-dose calcium without medical supervision.
May raise HbA1c
Monitor HbA1c if diabetic and combining both supplements.
Reduces drug levels
Monitor drug efficacy. Effect appears clinically minor.
Increases strontium absorption
Relevance mainly for strontium ranelate users.
Reduces supplement levels
Monitor if combining.
Note on hypercalcemia-related interactions: Toxic levels of vitamin D (causing hypercalcemia) can reduce verapamil effectiveness, induce arrhythmia with digoxin, and worsen with thiazide diuretics. These interactions only occur at toxic doses, not normal supplementation.
Studies show vitamin D supplement content frequently varies from label claims. Avelor recommends third-party verified products.
Not Prohibited. Not on the 2026 WADA list.
Studies show vitamin D supplement content frequently varies from label claims. Avelor recommends third-party verified products.
Reference identifiers on this page are being re-verified against PubMed. Some may not yet link to the paper named beside them.
**, Autier P et al. "Effect of vitamin D supplementation on non-skeletal disorders: a systematic review." *Lancet Diabetes Endocrinol*, 2017. Key finding: Vitamin D supplementation did not significantly reduce risk of cardiovascular disease, cancer, or fractures in vitamin D-sufficient populations.
Effect of vitamin D supplementation on non-skeletal disorders: a systematic review.. (2017). PMID: 32365423
**, Giustina A et al. "Consensus statement on vitamin D status assessment and supplementation." *Eur J Endocrinol*, 2020. Key finding: Target 25(OH)D level of 30-50 ng/mL recommended. Deficiency (<20 ng/mL) requires 50,000 IU weekly for 6-8 weeks followed by maintenance.
Consensus statement on vitamin D status assessment and supplementation.. (2020). PMID: 34607398
Based on independent third-party laboratory analysis
Category pass rate: ~90% pass rate. One notable failure: Biotics Research at 195% of label (nearly double).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated: April 5, 2026
Not medical advice. Based on published clinical research and systematic reviews.
Vitamin D · interaction landscape
4 flagged
0
Dangerous
4
Moderate
0
Timing
0
Pre-op
Safety
Moderate interactions. Monitoring, timing separation, or dose adjustment may be required.
Thiazide diuretics (HCTZ)
SourceClinical standard
Steroids (prednisone)
SourceClinical standard
Orlistat (Alli)
SourceFDA label
Cholestyramine (bile acid sequestrant)
SourceFDA label
Educational information only. This is not medical advice. These statements have not been evaluated by the FDA. Talk to your prescriber before starting, stopping, or combining any supplement with prescription medication.